eagle1462010
Diamond Member
- May 17, 2013
- 69,319
- 34,352
- 2,290
Who are these WE PEOPLE..........I said if you have a problem with THESE STUDIES...........contact those professionals that did the studies..............Because we don’t know if those cross reactive antibodies confer immunity or decrease susceptibility to COVID 19.Exactly WHAT IS DIFFICULT about the studies I JUST POSTED AGAIN.........hmmm..........Do you have a Reading comprehension problem..........hmmmPeople with no experience throw scientific studies around all the time as if they actually understand wha they’re talking about.
It states CLEARLY.....that in the Study.....40 to 60 % have some immunity or immunity with the virus.............because of past corona viruses......and the body's T Cells remember how to fight it.
Which is why under 50 the death rate is like .001%...........But that doesn't push the FEAR NARRATIVE your side has been pushing from the beginning............I posted the studies from the beginning of this.......and still do...........OH WELL.
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and…www.sciencedirect.com
Summary
Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic control measures. Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in ∼70% and 100% of COVID-19 convalescent patients, respectively. CD4+ T cell responses to spike, the main target of most vaccine efforts, were robust and correlated with the magnitude of the anti-SARS-CoV-2 IgG and IgA titers. The M, spike, and N proteins each accounted for 11%–27% of the total CD4+ response, with additional responses commonly targeting nsp3, nsp4, ORF3a, and ORF8, among others. For CD8+ T cells, spike and M were recognized, with at least eight SARS-CoV-2 ORFs targeted. Importantly, we detected SARS-CoV-2-reactive CD4+ T cells in ∼40%–60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating “common cold” coronaviruses and SARS-CoV-2.
Their names are in the studies.............go tell them how wrong they are in these studies......I'm sure they will listen to you.........LOL